Detalhe da pesquisa
1.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood
; 141(6): 567-578, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399715
2.
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
N Engl J Med
; 384(10): 924-935, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704937
3.
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
Blood
; 139(8): 1177-1183, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797911
4.
Mutation Clearance after Transplantation for Myelodysplastic Syndrome.
N Engl J Med
; 379(11): 1028-1041, 2018 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30207916
5.
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
J Natl Compr Canc Netw
; 19(1): 16-27, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406488
6.
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 26(12): 2223-2228, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829079
7.
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia.
Blood
; 131(8): 855-863, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203585
8.
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
N Engl J Med
; 375(21): 2023-2036, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959731
9.
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.
Blood
; 129(24): 3175-3183, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28468797
10.
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(6): 721-749, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200351
11.
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
Haematologica
; 107(7): 1709-1713, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236053
12.
Mutation Clearance after Transplantation for Myelodysplastic Syndrome.
N Engl J Med
; 379(24): 2380, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575467
13.
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes.
Am J Hematol
; 96(4): E111-E114, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33448430
14.
Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon.
Blood
; 122(15): e44-51, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24009227
15.
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen.
Biol Blood Marrow Transplant
; 20(1): 46-52, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24120526
16.
Exome analysis of treatment-related AML after APL suggests secondary evolution.
Br J Haematol
; 185(5): 984-987, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30467844
17.
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy.
Blood
; 129(10): 1397-1401, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082444
18.
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.
Am J Hematol
; 89(8): E103-8, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24723466
19.
Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia.
Am J Hematol
; 89(5): 487-92, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24415560
20.
Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report.
Cancer Genet
; 280-281: 1-5, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056049